These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32431512)

  • 1. MiR-138 Suppresses the PDK1 Expression to Decrease the Oxaliplatin Resistance of Colorectal Cancer.
    Wang Y; Zhang D; Li Y; Fang F
    Onco Targets Ther; 2020; 13():3607-3618. PubMed ID: 32431512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway.
    Zhang Y; Liu X; Zhang J; Xu Y; Shao J; Hu Y; Shu P; Cheng H
    Aging (Albany NY); 2020 Mar; 12(7):5640-5650. PubMed ID: 32209726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
    Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
    Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2.
    Sun W; Ge Y; Cui J; Yu Y; Liu B
    Mol Ther Oncolytics; 2021 Jun; 21():87-97. PubMed ID: 33981825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p/AVEN axis.
    Ge T; Zhang Y
    Open Med (Wars); 2022; 17(1):1228-1240. PubMed ID: 35892081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-325 Promotes Oxaliplatin-Induced Cytotoxicity Against Colorectal Cancer Through the HSPA12B/PI3K/AKT/Bcl-2 Pathway.
    Zhang L; Chen H; Song Y; Gu Q; Zhang L; Xie Q; Xu J; Zhang M
    Dig Dis Sci; 2021 Aug; 66(8):2651-2660. PubMed ID: 32914380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1.
    Liu H; Cheng XH
    Oncotarget; 2018 Feb; 9(15):12304-12315. PubMed ID: 29552311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p.
    Ghanbarian M; Afgar A; Yadegarazari R; Najafi R; Teimoori-Toolabi L
    Biomed Pharmacother; 2018 Dec; 108():1070-1080. PubMed ID: 30372807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
    Wu YZ; Lin HY; Zhang Y; Chen WF
    J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
    Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
    PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of miR-96 enhances the sensitivity of colorectal cancer cells to oxaliplatin by targeting TPM1.
    Ge T; Xiang P; Mao H; Tang S; Zhou J; Zhang Y
    Exp Ther Med; 2020 Sep; 20(3):2134-2140. PubMed ID: 32765688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
    Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
    Qin Y; Li L; Wang F; Zhou X; Liu Y; Yin Y; Qi X
    Cell Physiol Biochem; 2018; 48(4):1628-1637. PubMed ID: 30071508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00963/miR-4458 regulates the effect of oxaliplatin in gastric cancer by mediating autophagic flux through targeting of ATG16L1.
    Hou M; Li C; Dong S
    Sci Rep; 2021 Oct; 11(1):20951. PubMed ID: 34697403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of miR-29a facilitates apoptosis of colorectal carcinoma cell SW480 and suppresses its Paclitaxel resistance.
    Yuan LL; Li L; Liu JN; Mei J; Lei CJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5499-5507. PubMed ID: 30229821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of MiR-20a Enhances Sensitivity of Colorectal Cancer Cells to Cisplatin by Increasing ASK1 Expression.
    Zhang L; He L; Zhang H; Chen Y
    Cell Physiol Biochem; 2018; 47(4):1432-1441. PubMed ID: 29940575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel exosomal miR-46146 transfer oxaliplatin chemoresistance in colorectal cancer.
    Xu Y; Zhu M
    Clin Transl Oncol; 2020 Jul; 22(7):1105-1116. PubMed ID: 31728833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.
    Chai H; Liu M; Tian R; Li X; Tang H
    Acta Biochim Biophys Sin (Shanghai); 2011 Mar; 43(3):217-25. PubMed ID: 21242194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.